Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.4%
    Check dated 2025-07-12T08:02:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.5%
    Check dated 2025-07-05T04:15:43.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-20T19:48:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to include detailed information about a Phase III clinical study evaluating pembrolizumab as a treatment for Stage III-IVA resectable locoregionally advanced head and neck squamous cell carcinoma. Key details such as study design, eligibility criteria, and locations for participation have been added.
    Difference
    100%
    Check dated 2025-06-13T16:23:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study information regarding a clinical trial for pembrolizumab in treating advanced head and neck squamous cell carcinoma. This includes critical data on study design, eligibility criteria, and locations involved in the trial.
    Difference
    91%
    Check dated 2025-06-06T10:03:17.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-30T04:48:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.